Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

SILCAAT

Project: Types of projectsProject

  1. ALCAR

    Project: Types of projectsProject

  2. BI Switch

    Project: Types of projectsProject

  3. CoDe

    Project: Types of projectsProject

  4. HIV-TB Project

    Project: Types of projectsProject

  5. NRTI sparing

    Project: Types of projectsProject

  6. ESPRIT002:STALWART

    Project: Types of projectsProject

  7. COHERE

    Project: Types of projectsProject

  8. PASS

    Project: Types of projectsProject

  9. SMART

    Project: Types of projectsProject

View graph of relations
A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-infected Patients with Low CD4+ Counts Under Active Antiretroviral Therapy (SILCAAT) The purpose of this study is to compare the effects of subcutaneous recombinant interleukin-2 (SC rIL-2) and no SC rIL-2 o­n disease progression and death over an average follow-up period of 6-7 years period in patients with HIV-1 infection o­n stable antiretroviral therapy who have a CD4+ cell count between 50 and 299 cells/mm3 and a viral load <10,000 copies/mL.
StatusCurrent
Period18/07/2011 → …
URLhttp://www.clinicaltrials.gov/ct/show/NCT00013611?order=1
Research programme<ingen navn>

ID: 32508764